Triple-Vessel Disease in a High-Risk Surgical Patient Treated With Nine Drug-Eluting Stents. [PDF]
Najam US, Ali Z.
europepmc +1 more source
抗炎症による再狭窄予防対策 : 遺伝子溶出ステントによる次世代血管内医療システムの開発(7. Drug-eluting stent時代の幕開けと新技術, <特集>第69回日本循環器学会学術集会)
健輔 江頭
openalex +2 more sources
A Prospective, Randomized Trial of Bioresorbable Polymer Drug-Eluting Stents versus Fully Bioresorbable Scaffolds in Patients Undergoing Coronary Stenting. [PDF]
Wiebe J+13 more
europepmc +1 more source
Current Status of and Future Prospects for Drug-Eluting Stents and Scaffolds in Infrapopliteal Arteries. [PDF]
Lim E, Varcoe RL.
europepmc +1 more source
Evaluation of safety and efficacy of intracranial self-expanding drug-eluting stents for symptomatic intracranial atherosclerotic stenosis: a prospective, multicentre, randomised controlled, superiority clinical trial protocol. [PDF]
Zhu Z+11 more
europepmc +1 more source
Drug-Eluting Balloons and Drug-Eluting Stents in Diabetic Patients Undergoing Percutaneous Coronary Intervention Due to Restenosis-DM-Dragon Registry. [PDF]
Niezgoda P+22 more
europepmc +1 more source
A Meta-Analysis of 3-Year Outcomes of Drug-Coated Balloons Versus Drug-Eluting Stents for Small-Vessel Coronary Artery Disease. [PDF]
Dobromir Angheluta A+6 more
europepmc +1 more source